期刊文献+

新降糖颗粒对2型糖尿病大鼠胰岛素抵抗及肝脏GK表达的影响 被引量:5

Effects of Xinjiangtang Granules on Insulin Resistance and Hepatic GK mRNA Expression in Type 2 Diabetes Mellitus Rats
原文传递
导出
摘要 目的:观察新降糖颗粒对2型糖尿病(type 2 diabetes mellitus,T2DM)大鼠血清空腹胰岛素水平(fasting insulin,FINS),超氧化物歧化酶(superoxide dismutase,SOD),丙二醛(malondialdehyde,MDA),C-反应蛋白(C-react protein,CRP)及肝脏葡萄糖激酶(glucokinase,GK)基因的影响,探讨其降糖机制。方法:将SD大鼠随机分为正常对照组和糖尿病造模组。采用高脂饮食联合小剂量ip链脲佐菌素(STZ)28 mg·kg-1建立2型糖尿病模型,造模成功后大鼠随机分为模型组,新降糖颗粒高、中、低剂量组(22.8,11.4,5.7 g·kg-1),二甲双胍组(0.15 g·kg-1)。正常对照组和模型组给予生理盐水,各给药组分别ig给予相应剂量药物。连续ig 5周后,氧化酶法检测大鼠空腹血糖(fasting blood-glucose,FBG)的变化;ELISA法检测大鼠血清中的FINS,CRP的变化;试剂盒检测大鼠血清中SOD,MDA的水平;RT-qPCR法检测肝脏中GK mRNA的表达。结果:与正常对照组比较,模型组中大鼠的FBG,胰岛素抵抗指数(insulin resistance index,IRI)及血清中FINS,CRP含量均显著升高(P<0.01),血清中SOD活性明显降低(P<0.01),新降糖颗粒高、中、低剂量组FBG,IRI,FINS,CRP活性均明显降低(P<0.05,P<0.01),SOD活性明显升高(P<0.05,P<0.01);模型组大鼠肝脏中GK mRNA的表达明显降低(P<0.05),新降糖颗粒中、低剂量组GK mRNA表达量显著升高(P<0.01)。结论:新降糖颗粒能明显降低T2DM大鼠血糖,其可能的作用机制是通过降低糖尿病IRI水平,增强抗氧化应激能力,减轻炎症反应,以及提高肝脏GK mRNA水平而起作用。 Objective:To observe the effects of the Xinjiangtang granule on the serum levels of insulin,superoxide dismutase (SOD),malondialdehyde (MDA),C-reactive protein (CRP) and the expression of hepatic glucokinase (GK) mRNA in type 2 diabetes mellitus (T2DM) rats,and to explore its anti-diabetic mechanisms.Method:SD rats were randomly divided into normal group and diabetic group.The model of T2DM rats were established by feeding with high fat diet and injecting low dosage of streptozotocin (STZ) at 28 mg ·kg^-1 Then the rats in diabetic group were randomly divided into model group,metformin group (0.15 mg ·kg^-1),and low-,medium-,high-dosage groups of Xinjiangtang granule (22.8,11.4,5.7 g ·kg^-1).The rats in normal and model groups were given the same dosage of normal saline.All rats received oral administration of corresponding medicines for 5 weeks.The levels of fosting blood glucose (FBG) were assayed by oxidase method.The serum levels of fasting insulin (FINS) and CRP were assayed by ELISA.The serum levels of SOD and MDA were detecteded by assay kits.The expression of GK mRNA was detected by RT-qPCR.Result:Compared with the normal group,the levels of FBG,insulin resistance index (IRI),FINS,CRP showed obvious increase (P 〈0.01),and serum SOD level showed an obvious decrease in the model group (P 〈 0.01).The levels of FBG,IRI,MDA,CRP of the high-,medium-and low-dosage Xinjiangtang granule group showed obvious decrease (P 〈 0.01),the levels of FBG,IRI,FINS,CRP showed obvious decrease (P 〈 0.05,P 〈 0.01) in the low-dosage Xinjiangtang granule group,and serum SOD level showed an obvious increase as compared with those in model group (P 〈0.05,P 〈0.01).The expression of hepatic GK mRNA showed an obvious decrease in model group as compared with that in normal group (P 〈 0.05).While it showed an obvious increase in medium-and low-dosage Xinjiangtang granule group as compared with that in model group (P 〈0.01).Conclusion:The Xinjiangtang granule can significantly reduce the blood glucose level in T2DM rats,which may be achieved by reducing FINS level,enhancing the capacity of resistance to oxidative stress,relieving inflammation and improving the hepatic GK mRNA level.
出处 《中国实验方剂学杂志》 CAS 北大核心 2014年第20期177-181,共5页 Chinese Journal of Experimental Traditional Medical Formulae
基金 广东省科技计划基金项目(2012B060300029) 广东省医学科研基金项目(B2012187) 广州市科技攻关项目(201300000157)
关键词 糖尿病 新降糖颗粒 氧化应激 胰岛素抵抗 葡萄糖激酶 diabetes Xinjiangtang granule oxidative stress insulin resistance glucokinase
  • 相关文献

参考文献15

  • 1Chan J C, Malik V, Jia W, et al. Diabetes in asia: epidemiology, risk factors, and pathophysiology [ J]. JAMA, 2009, 301(20):2129.
  • 2Sieqel K, Narayan K M. The unite for diabetes campaign:overcoming constraints to find a global policy solution [J]. Global Health, 2008, 4(3):1.
  • 3Li W L, Zheng H C, Bukuru J, et al. Natural medicines used in the traditional Chinese medical system for therapy of diabetes mellitus [ J]. J Ethnopharmacol, 2004, 92(1):1.
  • 4梁丽娜,胡守玉,战丽彬,施翔,闫云,隋华,张福良.滋补脾阴方药对脾阴虚糖尿病大鼠海马胰岛素抵抗影响的实验研究[J].中国中西医结合杂志,2012,32(3):356-361. 被引量:31
  • 5Zelent D, Najafl H, Odili S, et al. Glucokinase and glucose homeostasis proven concepts and new ideas [J]. Biochem Soc Trans, 2005, 33(1):306.
  • 6Jung U J, Park Y B, Kim S R, et al. Supplementation of persimmon leaf ameliorates hyperglycemia, dyslipidemia and hepatic fat accumulation in type 2 diabetic mice [J]. PLoS One, 2012, 7(11):e49030.
  • 7Xiao Z Q, Wang Y L, Gan S R, et al. Polysaccharides from Liriopes Radix ameliorates hyperglycemia via various potential mechanisms in diabetic rats [ J]. J Sci Food Aqric, 2014, 94(5) :975.
  • 8汪建辉,欧瑜.葡萄糖激酶与糖尿病[J].药物生物技术,2012,19(6):552-556. 被引量:15
  • 9Watson J D. Type 2 diabetes as a redox disease [ J]. Lancet, 2014, 383(9919):841.
  • 10周文,王晖,杨元生,陈垦.中药有效成分治疗糖尿病的研究进展[J].广东药学院学报,2013,29(2):219-222. 被引量:13

二级参考文献75

共引文献87

同被引文献66

  • 1JI Xiao-mei,WANG Qian,GONG Mu-xin,DU Yu-qiong,JIA De-xian.Effects of Xiaoke granule on transforming growth factor-beta_1 expression and proliferation in rat mesangial cells[J].Chinese Medical Journal,2006(21):1839-1842. 被引量:3
  • 2张德贵,贺建丽,王富珍,李喜平,秦海金.消瘅汤对2型糖尿病患者糖脂代谢紊乱的影响[J].上海中医药杂志,2007,41(1):35-37. 被引量:3
  • 3王蓉蓉,谢琳,吴晓烨,王文艳,王芳,雷康福,方周溪,陈国荣.银杏叶提取物对实验性2型糖尿病大鼠肝脏的保护作用[J].中国病理生理杂志,2007,23(3):566-569. 被引量:24
  • 4Nacu N, Luzina I G, Highsmith K, et al. Macrophages produce TGF-beta-induced ( beta-ig-h3 ) following ingestion of apoptotic cells and regulate MMP14 levels and collagen turnover in fibroblasts [ J ]. J Immunol, 2008,180 ( 7 ) :5036-5044.
  • 5Mcknight A J, Savage D A, Patterson C C, et al. Resequencing of genes for transforming growth factor betal (TGF/3) type 1 and 2 receptors (TGF/3RI, TGF/3R2), and association analysis of variants with diabetic nephropathy [ J ]. BMC Med Genet, 2007, 8 (1):5.
  • 6Ha H, Lee H B. Reactive oxygen species and matrix remodeling in diabetic kidney [ J]. J Am Soc Nephrol, 2003,14 ( 8 ) : $246-$249.
  • 7Nam SM, LeeM Y, KohJH, etal. Effects of NADPH oxidase inhibitor on diabetic nephropathy in OLETF rats :the role of reducing oxidative stress in its protective property[ J]. Diabetes Res Clin Pract, 2009,83 ( 2 ) : 176-182.
  • 8The United States Pharmacopeial Convention. USP. NF35 [S]. USA:2012:61.
  • 9Reagan-Shaw S, Nihal M, Ahmad N. Dose translation from animal to human studies revisited [ J ]. FASEB Journal, 2008,22 ( 3 ) :659-661.
  • 10Veldman B, Vervoort G. Pathogenesis of renal microvascular complications in diabetes mellitus [ J ]. Neth J Med,2002,60(10) :390-396.

引证文献5

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部